Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECT OF DAFLON (DIOSMIN AND HESPERIDIN) ON POST-OPERATIVE SEROMA FORMATION IN BREAST CANCER SURGERY

NCT07588828 is registered in ClinicalTrials.gov with Ittefaq Hospital trust as lead sponsor.

NCT NCT07588828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECT OF DAFLON (DIOSMIN AND HESPERIDIN) ON POST-OPERATIVE SEROMA FORMATION IN BREAST CANCER SURGERY
Lead sponsor
Ittefaq Hospital trust
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2024
Completion date
April 15, 2026
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer surgery, post-operative seroma formation